EGF receptor trafficking: consequences for signaling and cancer
Highlights • EGF receptor endocytic traffic can regulate signaling and cell survival. • Signaling from activated EGFR occurs at the endosome as well as the cell surface. • Endocytosis can have positive and negative effects on signaling and tumorigenesis. • EGFR traffic promoted by antineoplastic the...
Gespeichert in:
Veröffentlicht in: | Trends in cell biology 2014-01, Vol.24 (1), p.26-34 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 34 |
---|---|
container_issue | 1 |
container_start_page | 26 |
container_title | Trends in cell biology |
container_volume | 24 |
creator | Tomas, Alejandra Futter, Clare E Eden, Emily R |
description | Highlights • EGF receptor endocytic traffic can regulate signaling and cell survival. • Signaling from activated EGFR occurs at the endosome as well as the cell surface. • Endocytosis can have positive and negative effects on signaling and tumorigenesis. • EGFR traffic promoted by antineoplastic therapy is important in tumor resistance. |
doi_str_mv | 10.1016/j.tcb.2013.11.002 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3884125</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0962892413001931</els_id><sourcerecordid>1490707608</sourcerecordid><originalsourceid>FETCH-LOGICAL-c572t-febfd2efe54239d8d446a17e6f6afff06aabe125140947bcd85e640a6b025e0f3</originalsourceid><addsrcrecordid>eNp9kUFv1DAQhS0EokvpD-CCcuSSMGM7jgNSK1S1BalSD6Vny3HGi7fZZLGzlfrvcbSlAg6cfHhv3ni-x9g7hAoB1cdNNbuu4oCiQqwA-Au2Qt20pQCtX7IVtIqXuuXyiL1JaQMADUfxmh1xydta13zFzi6uLotIjnbzFIs5Wu-Duw_j-lPhpjHRzz2NjlLhs5rCerRD1go79oWzWYhv2Stvh0QnT-8xu7u8-H7-tby-ufp2_uW6dHXD59JT53tOnmrJRdvrXkplsSHlVd7oQVnbEfIaJbSy6Vyva1ISrOqA1wReHLPTQ-5u322pdzTmvw5mF8PWxkcz2WD-Vsbww6ynByO0ljk4B3x4CohTPirNZhuSo2GwI037ZFC20ECjQGcrHqwuTilF8s9rEMwC3mxMBm8W8AbRZPB55v2f_3ue-E06Gz4fDJQpPQSKJrmwsO1Dxj-bfgr_jT_9Z9rlIoKzwz09UtpM-5iryVeYxA2Y26X5pXgUANgKFL8AI0Optw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1490707608</pqid></control><display><type>article</type><title>EGF receptor trafficking: consequences for signaling and cancer</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Collection</source><creator>Tomas, Alejandra ; Futter, Clare E ; Eden, Emily R</creator><creatorcontrib>Tomas, Alejandra ; Futter, Clare E ; Eden, Emily R</creatorcontrib><description>Highlights • EGF receptor endocytic traffic can regulate signaling and cell survival. • Signaling from activated EGFR occurs at the endosome as well as the cell surface. • Endocytosis can have positive and negative effects on signaling and tumorigenesis. • EGFR traffic promoted by antineoplastic therapy is important in tumor resistance.</description><identifier>ISSN: 0962-8924</identifier><identifier>EISSN: 1879-3088</identifier><identifier>DOI: 10.1016/j.tcb.2013.11.002</identifier><identifier>PMID: 24295852</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Antineoplastic Agents - pharmacology ; antineoplastic therapy ; Endocytosis ; epidermal growth factor receptor (EGFR) ; ErbB Receptors - antagonists & inhibitors ; ErbB Receptors - genetics ; ErbB Receptors - metabolism ; GRB2 Adaptor Protein - metabolism ; Humans ; Multivesicular Bodies - metabolism ; Mutation ; Neoplasms - drug therapy ; Neoplasms - metabolism ; Neoplasms - pathology ; oncogenes ; Pathology ; Protein Transport ; Proteolysis ; Review ; Signal Transduction ; trafficking ; Ubiquitination</subject><ispartof>Trends in cell biology, 2014-01, Vol.24 (1), p.26-34</ispartof><rights>Elsevier Ltd</rights><rights>2013 Elsevier Ltd</rights><rights>Copyright © 2013 Elsevier Ltd. All rights reserved.</rights><rights>2014 Elsevier Ltd. 2013 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c572t-febfd2efe54239d8d446a17e6f6afff06aabe125140947bcd85e640a6b025e0f3</citedby><cites>FETCH-LOGICAL-c572t-febfd2efe54239d8d446a17e6f6afff06aabe125140947bcd85e640a6b025e0f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0962892413001931$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24295852$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tomas, Alejandra</creatorcontrib><creatorcontrib>Futter, Clare E</creatorcontrib><creatorcontrib>Eden, Emily R</creatorcontrib><title>EGF receptor trafficking: consequences for signaling and cancer</title><title>Trends in cell biology</title><addtitle>Trends Cell Biol</addtitle><description>Highlights • EGF receptor endocytic traffic can regulate signaling and cell survival. • Signaling from activated EGFR occurs at the endosome as well as the cell surface. • Endocytosis can have positive and negative effects on signaling and tumorigenesis. • EGFR traffic promoted by antineoplastic therapy is important in tumor resistance.</description><subject>Animals</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>antineoplastic therapy</subject><subject>Endocytosis</subject><subject>epidermal growth factor receptor (EGFR)</subject><subject>ErbB Receptors - antagonists & inhibitors</subject><subject>ErbB Receptors - genetics</subject><subject>ErbB Receptors - metabolism</subject><subject>GRB2 Adaptor Protein - metabolism</subject><subject>Humans</subject><subject>Multivesicular Bodies - metabolism</subject><subject>Mutation</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - pathology</subject><subject>oncogenes</subject><subject>Pathology</subject><subject>Protein Transport</subject><subject>Proteolysis</subject><subject>Review</subject><subject>Signal Transduction</subject><subject>trafficking</subject><subject>Ubiquitination</subject><issn>0962-8924</issn><issn>1879-3088</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFv1DAQhS0EokvpD-CCcuSSMGM7jgNSK1S1BalSD6Vny3HGi7fZZLGzlfrvcbSlAg6cfHhv3ni-x9g7hAoB1cdNNbuu4oCiQqwA-Au2Qt20pQCtX7IVtIqXuuXyiL1JaQMADUfxmh1xydta13zFzi6uLotIjnbzFIs5Wu-Duw_j-lPhpjHRzz2NjlLhs5rCerRD1go79oWzWYhv2Stvh0QnT-8xu7u8-H7-tby-ufp2_uW6dHXD59JT53tOnmrJRdvrXkplsSHlVd7oQVnbEfIaJbSy6Vyva1ISrOqA1wReHLPTQ-5u322pdzTmvw5mF8PWxkcz2WD-Vsbww6ynByO0ljk4B3x4CohTPirNZhuSo2GwI037ZFC20ECjQGcrHqwuTilF8s9rEMwC3mxMBm8W8AbRZPB55v2f_3ue-E06Gz4fDJQpPQSKJrmwsO1Dxj-bfgr_jT_9Z9rlIoKzwz09UtpM-5iryVeYxA2Y26X5pXgUANgKFL8AI0Optw</recordid><startdate>20140101</startdate><enddate>20140101</enddate><creator>Tomas, Alejandra</creator><creator>Futter, Clare E</creator><creator>Eden, Emily R</creator><general>Elsevier Ltd</general><general>Elsevier Science Publishers</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20140101</creationdate><title>EGF receptor trafficking: consequences for signaling and cancer</title><author>Tomas, Alejandra ; Futter, Clare E ; Eden, Emily R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c572t-febfd2efe54239d8d446a17e6f6afff06aabe125140947bcd85e640a6b025e0f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>antineoplastic therapy</topic><topic>Endocytosis</topic><topic>epidermal growth factor receptor (EGFR)</topic><topic>ErbB Receptors - antagonists & inhibitors</topic><topic>ErbB Receptors - genetics</topic><topic>ErbB Receptors - metabolism</topic><topic>GRB2 Adaptor Protein - metabolism</topic><topic>Humans</topic><topic>Multivesicular Bodies - metabolism</topic><topic>Mutation</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - pathology</topic><topic>oncogenes</topic><topic>Pathology</topic><topic>Protein Transport</topic><topic>Proteolysis</topic><topic>Review</topic><topic>Signal Transduction</topic><topic>trafficking</topic><topic>Ubiquitination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tomas, Alejandra</creatorcontrib><creatorcontrib>Futter, Clare E</creatorcontrib><creatorcontrib>Eden, Emily R</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Trends in cell biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tomas, Alejandra</au><au>Futter, Clare E</au><au>Eden, Emily R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>EGF receptor trafficking: consequences for signaling and cancer</atitle><jtitle>Trends in cell biology</jtitle><addtitle>Trends Cell Biol</addtitle><date>2014-01-01</date><risdate>2014</risdate><volume>24</volume><issue>1</issue><spage>26</spage><epage>34</epage><pages>26-34</pages><issn>0962-8924</issn><eissn>1879-3088</eissn><abstract>Highlights • EGF receptor endocytic traffic can regulate signaling and cell survival. • Signaling from activated EGFR occurs at the endosome as well as the cell surface. • Endocytosis can have positive and negative effects on signaling and tumorigenesis. • EGFR traffic promoted by antineoplastic therapy is important in tumor resistance.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>24295852</pmid><doi>10.1016/j.tcb.2013.11.002</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0962-8924 |
ispartof | Trends in cell biology, 2014-01, Vol.24 (1), p.26-34 |
issn | 0962-8924 1879-3088 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3884125 |
source | MEDLINE; Elsevier ScienceDirect Journals Collection |
subjects | Animals Antineoplastic Agents - pharmacology antineoplastic therapy Endocytosis epidermal growth factor receptor (EGFR) ErbB Receptors - antagonists & inhibitors ErbB Receptors - genetics ErbB Receptors - metabolism GRB2 Adaptor Protein - metabolism Humans Multivesicular Bodies - metabolism Mutation Neoplasms - drug therapy Neoplasms - metabolism Neoplasms - pathology oncogenes Pathology Protein Transport Proteolysis Review Signal Transduction trafficking Ubiquitination |
title | EGF receptor trafficking: consequences for signaling and cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T14%3A02%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=EGF%20receptor%20trafficking:%20consequences%20for%20signaling%20and%20cancer&rft.jtitle=Trends%20in%20cell%20biology&rft.au=Tomas,%20Alejandra&rft.date=2014-01-01&rft.volume=24&rft.issue=1&rft.spage=26&rft.epage=34&rft.pages=26-34&rft.issn=0962-8924&rft.eissn=1879-3088&rft_id=info:doi/10.1016/j.tcb.2013.11.002&rft_dat=%3Cproquest_pubme%3E1490707608%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1490707608&rft_id=info:pmid/24295852&rft_els_id=S0962892413001931&rfr_iscdi=true |